Conrad Wai Sells Over 220,000 Clover Health Shares Indirectly
On May 28, 2026, Conrad Wai, CEO of Counterpart Health and a subsidiary of Clover Health Investments (CLOV), sold approximately $879,000 worth of shares in an indirect open-market transaction. The sale involved 220,426 shares at around $3.99 per share, with no change to his direct ownership levels.
Topics: clover health conrad wai sec filing stock sale